WARREN, N.J.--(BUSINESS WIRE)--Celgene Cellular Therapeutics (CCT), a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced initial results from a Phase I multicenter safety ...
WARREN, N.J.--(BUSINESS WIRE)--Celgene Cellular Therapeutics (CCT), a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced the U.S. Food and Drug Administration (FDA) has ...
Celgene Cellular Therapeutics (CCT), a wholly owned subsidiary of Celgene Corporation announced that its intellectual property estate was strengthened by the issuance of United States Patent No. 7,045 ...
Human Longevity Inc. (HLI) said today it agreed to acquire biobanking business LifebankUSA and the biomaterials program from Celgene Cellular Therapeutics (CCT). The price was not disclosed. HLI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback